David W. Griggs
8Patents
3h-index
13Co-inventors
50Inventor score
Filing activity: Apr 25, 2006 → Jul 30, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7452537B2 | P-cadherin antibodies | Emerging Cross-Sectional Technologies | 17 | Expired |
| US8716226B2 | 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists | Chemistry; Metallurgy | 11 | Active |
| US9085606B2 | Beta amino acid derivatives as integrin antagonists | Chemistry; Metallurgy | 4 | Active |
| US7928214B2 | P-cadherin antibodies | Emerging Cross-Sectional Technologies | 2 | Active |
| US10035778B2 | Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists | Chemistry; Metallurgy | 1 | Active |
| US8974781B2 | P-cadherin antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US10577330B2 | Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists | Chemistry; Metallurgy | 0 | Active |
| US11306084B2 | Integrin antagonists | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.